TauC3 Biologics Ltd, based at Stevenage Bioscience Catalyst, has secured around $2.5 million in new investor commitments, extending the company’s operating runway to Q2 2027 and accelerating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback